TNDM

SEC source: 0001438133-21-000050 · wf-form4_162156078319824.xml · derivative · entry 6

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 189 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.expiration_date: The expiration date for this warrant is August 31, 2021.

F2 · ownership.nature: The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.

SEC source: 0001438133-21-000050 · wf-form4_162156078319824.xml · nonDerivative · entry 4

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 14,523

F1 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.

F3 · ownership.nature: The securities are directly owed by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over the securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.

SEC source: 0001438133-21-000050 · wf-form4_162156078319824.xml · nonDerivative · entry 3

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 20,032

F1 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.

F2 · ownership.nature: The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.

SEC source: 0001438133-21-000050 · wf-form4_162156078319824.xml · nonDerivative · entry 2

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 14,635

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.

F3 · ownership.nature: The securities are directly owed by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over the securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.

SEC source: 0001438133-21-000050 · wf-form4_162156078319824.xml · nonDerivative · entry 1

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 20,189

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.

F2 · ownership.nature: The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.

SEC source: 0001438133-21-000038 · wf-form4_162155929717471.xml · derivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,021

Underlying: Common Stock · 2,021 shares

Expires not disclosed

F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000055 · wf-form4_162156087403237.xml · derivative · entry 5

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,940

Underlying: Common Stock · 7,940 shares

Expires not disclosed

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F7 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F8 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-21-000055 · wf-form4_162156087403237.xml · derivative · entry 4

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,599

Underlying: Common Stock · 2,599 shares

Expires not disclosed

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F6 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F6 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F6 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

SEC source: 0001438133-21-000055 · wf-form4_162156087403237.xml · derivative · entry 3

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,599

Underlying: Common Stock · 2,599 shares

Expires not disclosed

F3 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F4 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000062 · wf-form4_162156106659761.xml · derivative · entry 4

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,733

Underlying: Common Stock · 38,733 shares

Expires not disclosed

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F6 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-21-000062 · wf-form4_162156106659761.xml · derivative · entry 3

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,679

Underlying: Common Stock · 12,679 shares

Expires not disclosed

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F5 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F5 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F5 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

SEC source: 0001438133-21-000062 · wf-form4_162156106659761.xml · derivative · entry 2

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,679

Underlying: Common Stock · 12,679 shares

Expires not disclosed

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · derivative · entry 7

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 243 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.expiration_date: The expiration dates for these warrants are August 31, 2021 (135 shares), July 3, 2022 (54 shares) and August 21, 2022 (54 shares).

F3 · ownership.nature: The securities are held by the Berger Family Trust dated April 16, 2008.

SEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · derivative · entry 6

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,940

Underlying: Common Stock · 7,940 shares

Expires not disclosed

F4 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F8 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F9 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · derivative · entry 5

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,599

Underlying: Common Stock · 2,599 shares

Expires not disclosed

F4 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F7 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F7 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F7 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

SEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,599

Underlying: Common Stock · 2,599 shares

Expires not disclosed

F4 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F5 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F6 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Indirect · Berger Family Trust

Disclosed balance after: 242

F2 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.

F3 · ownership.nature: The securities are held by the Berger Family Trust dated April 16, 2008.

SEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Indirect · Berger Family Trust

Disclosed balance after: 443

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.

F3 · ownership.nature: The securities are held by the Berger Family Trust dated April 16, 2008.

SEC source: 0001438133-21-000059 · wf-form4_162156096535081.xml · derivative · entry 4

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,940

Underlying: Common Stock · 7,940 shares

Expires not disclosed

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F6 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-21-000059 · wf-form4_162156096535081.xml · derivative · entry 3

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,599

Underlying: Common Stock · 2,599 shares

Expires not disclosed

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F5 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F5 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F5 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

SEC source: 0001438133-21-000059 · wf-form4_162156096535081.xml · derivative · entry 2

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,599

Underlying: Common Stock · 2,599 shares

Expires not disclosed

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000057 · wf-form4_162156093285668.xml · derivative · entry 4

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,940

Underlying: Common Stock · 7,940 shares

Expires not disclosed

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F6 · derivative.exercise_date: The option shall vest as to twenty-five percent (25%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-21-000057 · wf-form4_162156093285668.xml · derivative · entry 3

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,599

Underlying: Common Stock · 2,599 shares

Expires not disclosed

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F5 · derivative.exercise_price: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F5 · derivative.exercise_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

F5 · derivative.expiration_date: Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.

SEC source: 0001438133-21-000057 · wf-form4_162156093285668.xml · derivative · entry 2

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,599

Underlying: Common Stock · 2,599 shares

Expires not disclosed

F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000053 · wf-form4_162156085255118.xml · derivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,205

Underlying: Common Stock · 2,205 shares

Expires not disclosed

F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000050 · wf-form4_162156078319824.xml · derivative · entry 5

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,205

Underlying: Common Stock · 2,205 shares

Expires not disclosed

F4 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F5 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F6 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000048 · wf-form4_162156055545539.xml · derivative · entry 1

Howell Peyton R · CIK 0001528056 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,653

Underlying: Common Stock · 1,653 shares

Expires not disclosed

F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000045 · wf-form4_162156030132018.xml · derivative · entry 1

Sodhi Rajwant · CIK 0001715325 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 735

Underlying: Common Stock · 735 shares

Expires not disclosed

F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000043 · wf-form4_162155981262640.xml · derivative · entry 1

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,205

Underlying: Common Stock · 2,205 shares

Expires not disclosed

F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000040 · wf-form4_162155942751025.xml · derivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,205

Underlying: Common Stock · 2,205 shares

Expires not disclosed

F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000064 · wf-form4_162161698900856.xml · derivative · entry 1

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,205

Underlying: Common Stock · 2,205 shares

Expires not disclosed

F1 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.

F3 · derivative.exercise_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

F3 · derivative.expiration_date: RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2013 Plan.

SEC source: 0001438133-21-000055 · wf-form4_162156087403237.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,816

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 17, 2020 through May 17, 2021. This transaction is also exempt under Rule 16b-3(c).

SEC source: 0001438133-21-000062 · wf-form4_162156106659761.xml · nonDerivative · entry 1

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,052

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 17, 2020 through May 17, 2021. This transaction is also exempt under Rule 16b-3(c).

SEC source: 0001438133-21-000060 · wf-form4_162156099967238.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,862

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 17, 2020 through May 17, 2021. This transaction is also exempt under Rule 16b-3(c).

SEC source: 0001438133-21-000059 · wf-form4_162156096535081.xml · nonDerivative · entry 1

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,961

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 17, 2020 through May 17, 2021. This transaction is also exempt under Rule 16b-3(c).

SEC source: 0001438133-21-000057 · wf-form4_162156093285668.xml · nonDerivative · entry 1

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,552

F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 17, 2020 through May 17, 2021. This transaction is also exempt under Rule 16b-3(c).

SEC source: 0001438133-21-000028 · wf-form4_161921700162090.xml · nonDerivative · entry 5

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 14,500

F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2021.

F4 · ownership.nature: The securities are directly owed by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over the securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.

SEC source: 0001438133-21-000028 · wf-form4_161921700162090.xml · nonDerivative · entry 4

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 20,000

F5 · kind: The shares were given as a bona fide gift to the Chris and Rebecca Twomey Family Foundation at the San Diego Foundation.

F6 · price: The price per share reflects the average of the high and low trading prices of the Company's stock on the transaction date.

F3 · ownership.nature: The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.

SEC source: 0001438133-21-000028 · wf-form4_161921700162090.xml · nonDerivative · entry 3

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 22,500

F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2021.

F3 · ownership.nature: The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.

SEC source: 0001438133-21-000028 · wf-form4_161921700162090.xml · nonDerivative · entry 2

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 15,901

F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2021.

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $95.00 to $95.24. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F4 · ownership.nature: The securities are directly owed by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over the securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.

SEC source: 0001438133-21-000028 · wf-form4_161921700162090.xml · nonDerivative · entry 1

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 25,901

F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2021.

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $95.00 to $95.24. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F3 · ownership.nature: The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.

SEC source: 0001438133-21-000021 · wf-form4_161601788924421.xml · nonDerivative · entry 6

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 452,390

F1 · shares: Shares sold are from long shares held by the Kim Blickenstaff Revocable Trust, dated April 15, 2010.

F8 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $88.73 to $88.99. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

SEC source: 0001438133-21-000021 · wf-form4_161601788924421.xml · nonDerivative · entry 5

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 453,490

F1 · shares: Shares sold are from long shares held by the Kim Blickenstaff Revocable Trust, dated April 15, 2010.

F7 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $87.71 to $88.70. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

SEC source: 0001438133-21-000021 · wf-form4_161601788924421.xml · nonDerivative · entry 4

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 477,318

F1 · shares: Shares sold are from long shares held by the Kim Blickenstaff Revocable Trust, dated April 15, 2010.

F6 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $86.71 to $87.70. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

SEC source: 0001438133-21-000021 · wf-form4_161601788924421.xml · nonDerivative · entry 3

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 497,912

F1 · shares: Shares sold are from long shares held by the Kim Blickenstaff Revocable Trust, dated April 15, 2010.

F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $85.58 to $86.56. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

SEC source: 0001438133-21-000021 · wf-form4_161601788924421.xml · nonDerivative · entry 2

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 503,412

F1 · shares: Shares sold are from long shares held by the Kim Blickenstaff Revocable Trust, dated April 15, 2010.

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $87.64 to $88.16. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

SEC source: 0001438133-21-000021 · wf-form4_161601788924421.xml · nonDerivative · entry 1

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 516,456

F1 · shares: Shares sold are from long shares held by the Kim Blickenstaff Revocable Trust, dated April 15, 2010.

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $86.64 to $87.64. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

SEC source: 0001438133-21-000019 · wf-form4_161559971577102.xml · derivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,854

Underlying: Common Stock · 8,646 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

SEC source: 0001438133-21-000019 · wf-form4_161559971577102.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,566

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $90.18 to $90.24. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

SEC source: 0001438133-21-000019 · wf-form4_161559971577102.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,212

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.